Panel members who voted 8-6 to recommend approval of BPC-157 and TB-500 argued that denying access would only push patients toward an unsafe gray market
Athletes use it to accelerate recovery and return to training faster while ensuring thorough tissue repair
Among bioactive peptides, GHK Cu peptide (glycyl-L-histidyl-L-lysine-copper) has experienced a surge of interest in both consumer products and scientific literature
Topical and Injectable GHK-Cu Routes Compared Topical GHK-Cu has published cosmetic, wound, and trial-context evidence, while injectable GHK-Cu lacks an FDA-approved dosing label and is specifically discussed by FDA in relation to compounded injectable safety concerns [2], [3], [7], [8]
Not intended for human consumption, clinical use, or as a drug, food, cosmetic, or medical device